Technologies that Improve Cancer Prevention and Diagnosis Experience
healthcaretechoutlook

Technologies that Improve Cancer Prevention and Diagnosis Experience

Healthcare Tech Outlook | Friday, December 31, 2021

Cancer is the second biggest cause of death worldwide, accounting for one in every six deaths. Individuals, families, institutions, and governments all bear a physical, emotional, and financial cost resulting from it.

FREMONT, CA: Cancer research remains a critical topic of study in healthcare worldwide. The inventions that resulted in the quick creation of the COVID-19 vaccine were first focused on curing cancer—for example, the mRNA technology. Today, it has evolved into a forward-thinking approach for cancer immunotherapy, and researchers anticipate that the area will continue to increase in the future.

Preventative and diagnostic measures

Cancer diagnosis must be precise and timely. Numerous cancer kinds are still not detectable early enough, while others are discovered but treated too harshly. This concept necessitates superior healthcare facilities, improved diagnostic tools, and patient proactivity. The following fields are expected to gain greater impetus in the next years.

Fluid biopsy: Fluid biopsy is a technique for analyzing tumors utilizing biomarkers found in bodily fluids such as blood. It can be used to diagnose cancer in its early stages. Re-biopsies are required during cancer treatment to alter the treatment regimen. This requires obtaining a new sample from the constantly evolving tumor to determine the next phase in the therapy. This is a significant difficulty for patients and medical practitioners alike when using current invasive biopsy procedures. The fluid biopsy is a technique for isolating cancer cells from a simple blood sample.

Cancer diagnosis in real-time: Numerous innovative methods are available for diagnosing tumors during surgery. A large-scale study published in 2019 discovered that over 20 percent of women diagnosed with breast cancer required a second procedure due to malignant cells remaining undiscovered the first time. A new tool, designated as a breakthrough device by the FDA in October 2020, tries to address this issue. The imaging equipment developed by OncoRes Medical makes critical intraoperative information available to surgeons during a lumpectomy. The handheld gadget utilizes artificial intelligence to aid in identifying tumor and healthy tissue, significantly boosting breast-conserving surgical outcomes and reducing repeat procedures for patients with breast cancer.

Recognize the genetic and behavioral factors that contribute to disease: By gaining detailed knowledge about the genetic and environmental elements that contribute to the development of various types of cancer, including the individual patient's genetic makeup, it would be possible to detect cancer in its infancy. This will necessitate procedural innovation in healthcare and the development of more accurate and specific cancer biomarkers, backed up by improved screening technology.

Weekly Brief